General Partner, Inc.
Source: SEC Form 13F · as of Mar 2026General Partner, Inc. holds 12 biotech & pharma companies tracked by BioSniper, totaling $7.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$7.1M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 10,818 | $2.6M |
| MRKMerck & Co., Inc. | 8,686 | $1.0M |
| PMPhilip Morris International Inc | 5,768 | $954K |
| ABTABBOTT LABORATORIES | 6,305 | $647K |
| LLYELI LILLY & Co | 585 | $538K |
| ABBVAbbVie Inc. | 2,044 | $445K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,396 | $378K |
| MCKMcKesson Corporation | 234 | $202K |
| NVONovo Nordisk A/S | 2,080 | $76K |
| AZNASTRAZENECA PLC | 384 | $76K |
| AMGNAMGEN INC | 211 | $74K |
| ELVElevance Health Inc. | 75 | $22K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.